We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
H.B. Fuller
FUL
$3.28B
| $10M | 0.01% |
154,849
-22,805
| -13% | -$1.48M |
|
952
COPT Defense Properties
CDP
$4.21B
| $9.99M | 0.01% |
370,312
+2,506
| +0.7% | +$71.3K |
|
|
TMHC
953
DELISTED
Taylor Morrison
TMHC
| $9.99M | 0.01% |
387,552
-7,540
| -2% | -$200K |
|
954
Haemonetics
HAE
$4B
| $9.98M | 0.01% |
141,333
+1,085
| +0.8% | +$68.5K |
|
955
FIVE9
FIVN
$2.6B
| $9.97M | 0.01% |
62,435
-863
| -1% | -$157K |
|
956
LiveRamp
RAMP
$2.3B
| $9.93M | 0.01% |
210,248
+1,478
| +0.7% | +$66.7K |
|
957
Progyny
PGNY
$2.2B
| $9.92M | 0.01% |
177,151
+52,439
| +42% | +$2.9M |
|
958
Meritage Homes
MTH
$4.86B
| $9.92M | 0.01% |
204,478
-31,298
| -13% | -$1.61M |
|
|
HBI
959
DELISTED
Hanesbrands
HBI
| $9.9M | 0.01% |
577,164
+204
| +0% | +$3.82K |
|
960
Cracker Barrel
CBRL
$1.29B
| $9.9M | 0.01% |
70,772
-780
| -1% | -$109K |
|
|
MIME
961
DELISTED
Mimecast Limited
MIME
| $9.88M | 0.01% |
155,366
+95,519
| +160% | +$5.85M |
|
|
JBGS
962
JBG SMITH
JBGS
$708M
| $9.87M | 0.01% |
333,163
-4,921
| -1% | -$152K |
|
963
Dolby
DLB
$5.79B
| $9.86M | 0.01% |
112,092
+34,331
| +44% | +$3.33M |
|
964
Royalty Pharma
RPRX
$25.2B
| $9.85M | 0.01% |
272,502
-16,754
| -6% | -$651K |
|
965
Qiagen
QGEN
$8.72B
| $9.83M | 0.01% |
179,362
-16,358
| -8% | -$911K |
|
966
Wendy's
WEN
$1.46B
| $9.81M | 0.01% |
452,321
-1,897
| -0.4% | -$43.2K |
|
967
Globant
GLOB
$1.61B
| $9.76M | 0.01% |
34,719
+636
| +2% | +$175K |
|
968
Sabre
SABR
$818M
| $9.74M | 0.01% |
823,042
-663
| -0.1% | -$7.52K |
|
|
CCMP
969
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $9.73M | 0.01% |
78,992
+81
| +0.1% | +$10.8K |
|
970
Apollo Global Management
APO
$73.4B
| $9.72M | 0.01% |
157,863
-103
| -0.1% | -$6.19K |
|
971
Elastic
ESTC
$7.81B
| $9.72M | 0.01% |
65,229
+343
| +0.5% | +$52.8K |
|
972
Avnet
AVT
$7.92B
| $9.71M | 0.01% |
262,707
-8,173
| -3% | -$323K |
|
973
Cerence
CRNC
$413M
| $9.69M | 0.01% |
100,855
+61,836
| +158% | +$6.75M |
|
974
Texas Capital Bancshares
TCBI
$4.32B
| $9.68M | 0.01% |
161,217
-885
| -0.5% | -$55.1K |
|
975
Diodes
DIOD
$4.84B
| $9.64M | 0.01% |
106,373
-13,640
| -11% | -$1.19M |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.